The proposed federal rules will require physicians and hospitals to use Electronic Health Records (EHRs) that prevent patient control over who can see and use sensitive personal health information.
This is the second time the federal government has proposed the use of technology that violates Americans’ strong rights to control the use and sale of their most sensitive personal information, from DNA to prescription records to diagnoses.
The proposed rules require EHRs to be able to show “meaningful use” (MU) and exchange of personal health data. PPR and other consumer and privacy advocacy groups submitted similar comments for the Stage 1 MU rules. These newly proposed rules are known as “Stage 2 MU” requirements for EHRs.
The most important function patients expect from electronic health systems is the power to control who can see and use their most sensitive personal information. Technologies that empower patients to decide who can see and use selected parts of their records have been working for 4 million people for over 10 years in 8 states with mental illness or addiction diagnoses. Today we do not have any way to know where our data flows, or who is using and selling it.
Even if we had a ‘chain of custody’ to prove who saw, used, or sold our personal health data—which we do not—it is still essential to restore patient control over personal health data so we can trust electronic health systems.
Technologies that require patient consent before data flows are cheap, effective, and should be required in all EHRs.
See Patient Privacy Rights’ formal comments on the Stage 2 MU proposed requirements submitted to the Centers for Medicare and Medicaid and the Office of the National Coordinator for Health IT at: http://patientprivacyrights.org/wp-content/uploads/2012/05/PPR-Comments-for-Stage-2MU-5-7-12.pdf